Rankings
▼
Calendar
LIVN Q1 2017 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$285M
-0.7% YoY
Gross Profit
$184M
64.7% margin
Operating Income
-$19M
-6.5% margin
Net Income
$11M
4.0% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
-8.2%
Cash Flow
Operating Cash Flow
$33M
Free Cash Flow
$26M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$636M
Stockholders' Equity
$1.7B
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$285M
$287M
-0.7%
Gross Profit
$184M
$163M
+12.9%
Operating Income
-$19M
-$36M
+48.4%
Net Income
$11M
-$40M
+127.9%
Revenue Segments
Cardiac Surgery
$139M
49%
Neuromodulation
$87M
31%
Cardiac Rhythm Management
$58M
20%
Geographic Segments
UNITED STATES
$114M
36%
Europe
$96M
30%
Non-U.S. and Europe
$74M
23%
FRANCE
$33M
10%
← FY 2017
All Quarters
Q2 2017 →